These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30258047)

  • 1. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.
    Osborne A; Khatib TZ; Songra L; Barber AC; Hall K; Kong GYX; Widdowson PS; Martin KR
    Cell Death Dis; 2018 Sep; 9(10):1007. PubMed ID: 30258047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons.
    Osborne A; Wang AXZ; Tassoni A; Widdowson PS; Martin KR
    Hum Gene Ther; 2018 Jul; 29(7):828-841. PubMed ID: 29466871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma.
    Wójcik-Gryciuk A; Gajewska-Woźniak O; Kordecka K; Boguszewski PM; Waleszczyk W; Skup M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB.
    Dekeyster E; Geeraerts E; Buyens T; Van den Haute C; Baekelandt V; De Groef L; Salinas-Navarro M; Moons L
    PLoS One; 2015; 10(11):e0142067. PubMed ID: 26560713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection.
    Chitranshi N; Dheer Y; Mirzaei M; Wu Y; Salekdeh GH; Abbasi M; Gupta V; Vander Wall R; You Y; Graham SL; Gupta V
    Mol Ther; 2019 Feb; 27(2):424-441. PubMed ID: 30341011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?
    Guo Y; Johnson E; Cepurna W; Jia L; Dyck J; Morrison JC
    Exp Eye Res; 2009 Dec; 89(6):921-33. PubMed ID: 19682984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.
    Martin KR; Quigley HA; Zack DJ; Levkovitch-Verbin H; Kielczewski J; Valenta D; Baumrind L; Pease ME; Klein RL; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4357-65. PubMed ID: 14507880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TrkB Receptor Agonist 7,8 Dihydroxyflavone is Protective Against the Inner Retinal Deficits Induced by Experimental Glaucoma.
    Gupta V; Chitranshi N; Gupta V; You Y; Rajput R; Paulo JA; Mirzaei M; van den Buuse M; Graham SL
    Neuroscience; 2022 May; 490():36-48. PubMed ID: 35217121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation.
    Igarashi T; Miyake K; Kobayashi M; Kameya S; Fujimoto C; Nakamoto K; Takahashi H; Igarashi T; Miyake N; Iijima O; Hirai Y; Shimada T; Okada T; Takahashi H
    Mol Vis; 2016; 22():816-26. PubMed ID: 27440998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of
    Shiozawa AL; Igarashi T; Kobayashi M; Nakamoto K; Kameya S; Fujishita S; Takahashi H; Okada T
    Mol Vis; 2020; 26():409-422. PubMed ID: 32565669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal application of AAV-BDNF or mutant AAV-CRMP2 protects retinal ganglion cells and stabilizes axons and myelin after partial optic nerve injury.
    Chiha W; Bartlett CA; Petratos S; Fitzgerald M; Harvey AR
    Exp Neurol; 2020 Apr; 326():113167. PubMed ID: 31904385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.
    Pease ME; McKinnon SJ; Quigley HA; Kerrigan-Baumrind LA; Zack DJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):764-74. PubMed ID: 10711692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma.
    Gupta V; You Y; Li J; Gupta V; Golzan M; Klistorner A; van den Buuse M; Graham S
    Biochim Biophys Acta; 2014 Sep; 1842(9):1567-78. PubMed ID: 24942931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Small Molecule TrkB Neurotrophin Receptor Partial Agonist as Possible Treatment for Experimental Nonarteritic Anterior Ischemic Optic Neuropathy.
    Ali Shariati M; Kumar V; Yang T; Chakraborty C; Barres BA; Longo FM; Liao YJ
    Curr Eye Res; 2018 Dec; 43(12):1489-1499. PubMed ID: 30273053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
    Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.
    Fu QL; Li X; Yip HK; Shao Z; Wu W; Mi S; So KF
    Neuroscience; 2009 Aug; 162(2):375-82. PubMed ID: 19422885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Brain-Derived Neurotrophic Factor Protects Large Retinal Ganglion Cells After Optic Nerve Crush in Mice.
    Feng L; Puyang Z; Chen H; Liang P; Troy JB; Liu X
    eNeuro; 2017; 4(1):. PubMed ID: 28101532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enriched environment during adolescence changes brain-derived neurotrophic factor and TrkB levels in the rat visual system but does not offer neuroprotection to retinal ganglion cells following axotomy.
    Franklin TB; Murphy JA; Myers TL; Clarke DB; Currie RW
    Brain Res; 2006 Jun; 1095(1):1-11. PubMed ID: 16730677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner.
    Abbasi M; Gupta VK; Chitranshi N; Gupta V; Ranjbaran R; Rajput R; Pushpitha K; Kb D; You Y; Salekdeh GH; Parton RG; Mirzaei M; Graham SL
    Theranostics; 2021; 11(13):6154-6172. PubMed ID: 33995651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.